Stoke Therapeutics
STOK
STOK
103 hedge funds and large institutions have $732M invested in Stoke Therapeutics in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% more funds holding
Funds holding: 81 → 103 (+22)
8.74% more ownership
Funds ownership: 108.41% → 117.15% (+8.7%)
16% less call options, than puts
Call options by funds: $1.9M | Put options by funds: $2.27M
Holders
103
Holding in Top 10
5
Calls
$1.9M
Puts
$2.27M
Top Buyers
| 1 | +$33M | |
| 2 | +$24.3M | |
| 3 | +$18.1M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$14.3M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$9.99M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$8.94M | |
| 3 | -$8.92M | |
| 4 |
CAC
Cowen and Company
New York
|
-$4.8M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.62M |